Domenica 13 Settembre 2026 – Aggiornato alle 20:40

Coronavirus Realtime

Oms approva uso emergenza vaccino Pfizer-BioNTech

di Luigi Cignoni, Direttore

epa08906066 A doctor holds vials containing the Pfizer/BioNTech Covid-19 vaccine during vaccinations at a nursing home of the German Red Cross (DRK) on the first day of the nationwide launch of Covid-19 vaccinations during the second wave of the coronavirus pandemic in Grossraeschen, Germany, 27 December 2020. Germany is beginning the vaccinations today mainly with mobile teams who are inoculating senior citizens in nursing homes. The volume of delivered vaccine is to rise sharply next week and many mass vaccination centers will open their doors in early January. EPA/Sean Gallup / POOL

L’Oms ha concesso la convalida di emergenza al vaccino Pfizer-BioNTech, aprendo così la strada ai paesi di tutto il mondo per approvarne rapidamente l’importazione e la distribuzione. Lo rende noto un comunicato dell’Organizzazione Mondiale della Sanità.

Leggi anche